Efficacy And Safety Of A Rotationally Asymmetric Refractive Multifocal Iol Implantation In Patients With Previous Corneal Laser Hyperopic Refractive Surgery.
Published 2024 - 42nd Congress of the ESCRS
Reference: PO608 | Type: Free paper | DOI: 10.82333/cnya-aw09
Authors: Alexander II Lanzuela Gonzales* 1 , Jorge Alió del Barrio 2 , Jorge Alió 2 , Katerina Nouzovska 3 , Ana Belen Plaza-Puche 4 , Mario Canto-Cerdan 4
1Research, Development and Innovation Department,Vissum Grupo Miranza,Alicante,Spain;Department of Ophthalmology,Ospital ng Makati,Makati,Philippines;Cornea, Cataract and Refractive Surgery Unit,Shinagawa Lasik and Aesthetics Center,Taguig,Philippines, 2Cornea, Cataract and Refractive Surgery Unit,Vissum Grupo Miranza,Alicante,Spain;Department of Ophthalmology,Universidad Miguel Hernández,Alicante,Spain, 3Research, Development and Innovation Department,Vissum Grupo Miranza,Alicante,Spain;Department of Ophthalmology,University Hospital in Hradec Králové,Hradec Králové,Czech Republic;Faculty of Medicine,Charles University,Hradec Králové,Czech Republic, 4Research, Development and Innovation Department,Vissum Grupo Miranza,Alicante,Spain
Purpose
To investigate the visual and refractive outcomes of patients implanted with a rotationally asymmetric refractive multifocal IOL (Lentis Mplus, Teleon) after cataract surgery in patients with previous hyperopic corneal laser refractive surgery.
Setting
Methods
Results
Conclusions
After cataract surgery, the LENTIS Mplus multifocal intraocular lens (IOL) was able to successfully improve the visual and refractive results at far and near distance in patients who had previously undergone hyperopic corneal laser refractive surgery.